QHM-2025-9472 A86005.99C..01

The NHS North East and North Cumbria Integrated Care Board is concluding a procurement process focused on health services, specifically for PSA Monitoring, Diabetes Care Planning, Shared Care Drug Monitoring, and Primary Care Investment. This contract, identified as QHM-2025-9472, is under the industry category of health services, with delivery located in the UK region of North East and Cumbria. The procurement stage is at award status, with the award decision made on 1 October 2025, and the contract slated to begin on 1 April 2025, ending on 31 March 2026.

This process follows the Direct Award Process A under the Health Care Services (Provider Selection Regime) regulations 2023, and notably this particular award operates outside the typical scope of the Procurement Act 2023 and Procurement Regulations 2024. This tender presents a unique opportunity for established health service providers, as it entails a direct award with no prior call for competition, making it suitable mainly for parties that can demonstrate they are realistically the sole capable provider. Although the contract value is registered as nominally minimal, the nature of this activity-based contract could foster business growth through expanded service offerings in the health care sector.

West Farm Surgery, a large-scale entity, has been identified as the successful supplier, providing a clear signal to other similar scale service providers regarding the type of organisation likely to benefit from this procurement approach. Business growth is feasible for providers who can bring innovative and efficient health care solutions compatible with regional health service needs.